Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction and communication, repetitive behaviors, and altered brain plasticity. Emerging evidence indicates that impairment in the serotonergic system, particularly involving serotonin receptor 7 (5-HT7 receptor), plays a crucial role in ASD pathophysiology. In this study, we investigated the synaptic alterations in the brain of juvenile and adult BTBR T + Itpr3tf/J (BTBR) mice, a well-established ASD model, emphasizing the pivotal role of 5-HT7 receptor in regulating synaptic morphology and functions. Our analyses revealed a significant alteration of pre- and post-synaptic proteins expression, impaired synaptic protein synthesis, and abnormal dendritic spine morphology in the brain cortex of BTBR mice. These synaptic deficits were accompanied by a reduction in 5-HT7 receptor expression in brain cortex synaptosomes of BTBR mice, underscoring the importance of 5-HT7 receptor in maintaining synaptic homeostasis. Remarkably, pharmacological activation of 5-HT7 receptor with the selective agonist LP-211 restored synaptic protein synthesis and ameliorated dendritic spine abnormalities in brain cortex of BTBR mice. Altogether, our findings provide new insights into the molecular underpinnings of ASD, suggesting that targeting the 5-HT7 receptor is a promising therapeutic approach to address synaptic dysfunctions in neurodevelopmental disorders.

Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of autism spectrum disorder / Filiz, Kardelen Dalim; Abate, Natalia; Pizzella, Amelia; Ferraro, Maria Grazia; Speranza, Luisa; Cristiano, Claudia; Mollica, Maria Pina; Di Giaimo, Rossella; Miniaci, Maria Concetta; Lacivita, Enza; Leopoldo, Marcello; Perrone-Capano, Carla; Crispino, Marianna; Volpicelli, Floriana. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 1879-0712. - 1019:(2026). [10.1016/j.ejphar.2026.178689]

Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of autism spectrum disorder

Filiz, Kardelen Dalim;Abate, Natalia;Pizzella, Amelia;Ferraro, Maria Grazia;Speranza, Luisa;Cristiano, Claudia;Mollica, Maria Pina;Di Giaimo, Rossella;Miniaci, Maria Concetta;Perrone-Capano, Carla;Crispino, Marianna
Co-ultimo
;
Volpicelli, Floriana
Co-ultimo
2026

Abstract

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social interaction and communication, repetitive behaviors, and altered brain plasticity. Emerging evidence indicates that impairment in the serotonergic system, particularly involving serotonin receptor 7 (5-HT7 receptor), plays a crucial role in ASD pathophysiology. In this study, we investigated the synaptic alterations in the brain of juvenile and adult BTBR T + Itpr3tf/J (BTBR) mice, a well-established ASD model, emphasizing the pivotal role of 5-HT7 receptor in regulating synaptic morphology and functions. Our analyses revealed a significant alteration of pre- and post-synaptic proteins expression, impaired synaptic protein synthesis, and abnormal dendritic spine morphology in the brain cortex of BTBR mice. These synaptic deficits were accompanied by a reduction in 5-HT7 receptor expression in brain cortex synaptosomes of BTBR mice, underscoring the importance of 5-HT7 receptor in maintaining synaptic homeostasis. Remarkably, pharmacological activation of 5-HT7 receptor with the selective agonist LP-211 restored synaptic protein synthesis and ameliorated dendritic spine abnormalities in brain cortex of BTBR mice. Altogether, our findings provide new insights into the molecular underpinnings of ASD, suggesting that targeting the 5-HT7 receptor is a promising therapeutic approach to address synaptic dysfunctions in neurodevelopmental disorders.
2026
Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of autism spectrum disorder / Filiz, Kardelen Dalim; Abate, Natalia; Pizzella, Amelia; Ferraro, Maria Grazia; Speranza, Luisa; Cristiano, Claudia; Mollica, Maria Pina; Di Giaimo, Rossella; Miniaci, Maria Concetta; Lacivita, Enza; Leopoldo, Marcello; Perrone-Capano, Carla; Crispino, Marianna; Volpicelli, Floriana. - In: EUROPEAN JOURNAL OF PHARMACOLOGY. - ISSN 1879-0712. - 1019:(2026). [10.1016/j.ejphar.2026.178689]
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0014299926001718-main.pdf

non disponibili

Dimensione 5.75 MB
Formato Adobe PDF
5.75 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1037587
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact